Sio Capital Management, LLC Leap Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.6 - $3.35 $704,000 - $1.47 Million	-440,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $594,000 - $1.76 Million	440,000 New	440,000 $1.76 Million
Q4 2020 Feb 16, 2021	SELL	$1.49 - $2.37 $2.16 Million - $3.44 Million	-1,451,998 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.68 - $2.17 $84,000 - $108,500	-50,000 Reduced 3.33%	1,451,998 $2.88 Million
Q2 2020 Aug 14, 2020	BUY	$1.39 - $2.84 $559,413 - $1.14 Million	402,456 Added 36.6%	1,501,998 $3.14 Million
Q1 2020 May 15, 2020	BUY	$1.06 - $2.94 $660,718 - $1.83 Million	623,319 Added 130.89%	1,099,542 $1.74 Million
Q4 2019 Feb 14, 2020	BUY	$0.63 - $1.37 $300,020 - $652,425	476,223 New	476,223 $533,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $263M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.